Towards Healthcare
Generic Drugs Market Size, Companies, Trends Report (2023 - 2032)

Generic Drugs Market Size Envisioned at USD 738.53 Billion by 2032

The report covers Generic Drugs Market Size and Companies segmented by drug class into simple generics, super generics and complex generics, by route of administration including oral, injectable, dermal and inhaler and by therapeutic application covering oncology, CNS, systemic anti-infectives, gastrointestinal, cardiovascular, musculoskeletal and others. Distribution channels comprise hospitals pharmacies, retail pharmacies and online pharmacies. The report offers the value (in USD Billion) for the above segments.

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Generic Drugs Market Assessment

  • Overview
  • Global Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Simple Generics
    • Super Generics
    • Complex Generics
  • Global Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Injectable
    • Demal and Inhaler
  • Global Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Application (2021 – 2033)
    • Oncology
    • Central Nervous system
    • Systemic Anti-infectives
    • Gastrointestinal
    • Cardiovascular
    • Musculoskeletal
    • Others
  • Global Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospitals Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
    • Asia-Pacific
      • China
      • India
      • Japan
      • South Korea
      • Malaysia
      • Philippines
    • Latin America
      • Brazil
      • Rest of Latin America
    • Middle East & Africa (MEA)
      • GCC
      • North Africa
      • South Africa
      • Rest of the Middle East & Africa

North America Generic Drugs Market Assessment

  • Overview
  • North America Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Simple Generics
    • Super Generics
    • Complex Generics
  • North America Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Injectable
    • Demal and Inhaler
  • North America Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Application (2021 – 2033)
    • Oncology
    • Central Nervous system
    • Systemic Anti-infectives
    • Gastrointestinal
    • Cardiovascular
    • Musculoskeletal
    • Others
  • North America Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospitals Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • North America Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Country (2021 – 2033)
    • U.S.
    • Canada

Europe Generic Drugs Market Assessment

  • Overview
  • Europe Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Simple Generics
    • Super Generics
    • Complex Generics
  • Europe Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Injectable
    • Demal and Inhaler
  • Europe Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Application (2021 – 2033)
    • Oncology
    • Central Nervous system
    • Systemic Anti-infectives
    • Gastrointestinal
    • Cardiovascular
    • Musculoskeletal
    • Others
  • Europe Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospitals Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Europe Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Country (2021 – 2033)
    • U.K.
    • Germany
    • France

Asia-Pacific Generic Drugs Market Assessment

  • Overview
  • Asia-Pacific Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Simple Generics
    • Super Generics
    • Complex Generics
  • Asia-Pacific Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Injectable
    • Demal and Inhaler
  • Asia-Pacific Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Application (2021 – 2033)
    • Oncology
    • Central Nervous system
    • Systemic Anti-infectives
    • Gastrointestinal
    • Cardiovascular
    • Musculoskeletal
    • Others
  • Asia-Pacific Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospitals Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Asia-Pacific Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Country (2021 – 2033)
    • China
    • India
    • Japan
    • South Korea
    • Malaysia
    • Philippines

Latin America Generic Drugs Market Assessment

  • Overview
  • Latin America Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Simple Generics
    • Super Generics
    • Complex Generics
  • Latin America Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Injectable
    • Demal and Inhaler
  • Latin America Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Application (2021 – 2033)
    • Oncology
    • Central Nervous system
    • Systemic Anti-infectives
    • Gastrointestinal
    • Cardiovascular
    • Musculoskeletal
    • Others
  • Latin America Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospitals Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Latin America Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Country (2021 – 2033)
    • Brazil
    • Rest of Latin America

Middle East & Africa (MEA) Generic Drugs Market Assessment

  • Overview
  • Middle East & Africa (MEA) Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Simple Generics
    • Super Generics
    • Complex Generics
  • Middle East & Africa (MEA) Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Injectable
    • Demal and Inhaler
  • Middle East & Africa (MEA) Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Application (2021 – 2033)
    • Oncology
    • Central Nervous system
    • Systemic Anti-infectives
    • Gastrointestinal
    • Cardiovascular
    • Musculoskeletal
    • Others
  • Middle East & Africa (MEA) Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospitals Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Middle East & Africa (MEA) Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Country (2021 – 2033)
    • GCC
    • North Africa
    • South Africa
    • Rest of the Middle East & Africa

Company Profiles

  • Mylan N.V.
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Abbott Laboratories
  • ALLERGAN
  • Teva Pharmaceutical Industries Ltd.
  • Eli Lilly and Company
  • STADA Arzneimittel AG
  • GlaxoSmithKline Plc.
  • Baxter International Inc.
  • Pfizer Inc.
  • Sandoz International GmbH

Conclusion & Recommendations

  • Insight Code: 5053
  • No. of Pages: 150
  • Format: PDF/PPT/Excel
  • Published: June 2023
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Rohan Patil is a seasoned market research professional with over 5 years of experience specializing in the healthcare sector. His expertise spans various facets of healthcare, including market dynamics, emerging trends, regulatory changes, and technology-driven innovations. With a keen eye for detail and a deep understanding of the global healthcare landscape, Rohan has been instrumental in shaping actionable insights that guide healthcare organizations in making informed, data-driven decisions.

Rohan's extensive experience covers a wide range of healthcare segments, from pharmaceuticals and biotechnology to medical devices and digital health. He has worked on numerous projects that evaluate market potential, assess competitive landscapes, and identify growth opportunities in rapidly evolving sectors in the healthcare industry.

His analytical acumen and ability to synthesize complex data have made him a trusted advisor to healthcare companies, helping them navigate the challenges and opportunities within the healthcare ecosystem. Rohan is particularly passionate about how technology and innovation are reshaping healthcare delivery, and his reports provide valuable insights into the impact of digital transformation on patient care, outcomes, and cost-efficiency.

With a strong track record in healthcare market research, Rohan continues to contribute significantly to the advancement of the industry by delivering data-backed strategies and comprehensive market analysis.

FAQ's

The generic drugs market promotes competition, helps lower healthcare costs, and increases access to medications. It allows healthcare systems to allocate resources more efficiently and provides patients with more affordable treatment options.

Yes, generic drugs are held to the same rigorous standards of quality, safety, and efficacy as brand-name drugs. Regulatory authorities closely monitor and regulate the manufacturing and distribution of generic drugs to ensure they meet these standards.

The generic drugs market faces challenges such as market saturation, pricing pressures, complex regulatory processes, and the need for continuous research and development to stay competitive.

Department of Pharmaceuticals | Government of India

Warning: include(report-detail-graphs.php): failed to open stream: No such file or directory in /home/thealthcre/public_html/report-toc.php on line 515

Warning: include(): Failed opening 'report-detail-graphs.php' for inclusion (include_path='.:/opt/cpanel/ea-php74/root/usr/share/pear') in /home/thealthcre/public_html/report-toc.php on line 515